Takeda and Cognition Kit partner in study to pilot wearable software in patients with Major Depressive Disorder (MDD)

Corporate Breaking News

Home : Takeda and Cognition Kit partner in study to pilot wearable software in patients with Major Depressive Disorder (MDD)

Feb 23 2017	Takeda and Cognition Kit partner in study to pilot wearable software in patients with Major Depressive Disorder (MDD)
CAMBRIDGE, England and DEERFIELD, Ill., Feb. 23, 2017 /PRNewswire/ -- Takeda Pharmaceuticals U.S.A., Inc., a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502) and Cognition Kit Limited, a joint venture between Cambridge Cognition Holdings PLC and Ctrl Group...


Source:http://www.prnewswire.com/news-releases/takeda-and-cognition-kit-partner-in-study-to-pilot-wearable-software-in-patients-with-major-depressive-disorder-mdd-300412199.html

Related News
» House speaker gets firsthand look at US-Mexico border » Sercomm Launches the World's First LWA Small Cell Solution